![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Public Health Impact of HCV Screening and Treatment
in the French Baby-Boomer Population
|
|
|
Reported by Jules Levin
EASL 2013 April 22-26 Vienna Austria
O. Ethgen1,2, Y. Sanchez Gonzalez3, G. Jeanblanc3, T.R. Juday3
1SERFAN innovation, Namur, Belgium, 2University of Liege, Liege, Belgium, 3AbbVie, Inc., North Chicago, IL, United States
![EASL1.gif](../images/051815/051815-1/EASL1.gif)
![EASL2.gif](../images/051815/051815-1/EASL2.gif)
![EASL3.gif](../images/051815/051815-1/EASL3.gif)
![EASL4.gif](../images/051815/051815-1/EASL4.gif)
![EASL5.gif](../images/051815/051815-1/EASL5.gif)
![EASL6.gif](../images/051815/051815-1/EASL6.gif)
![EASL7.gif](../images/051815/051815-1/EASL7.gif)
![EASL8.gif](../images/051815/051815-1/EASL8.gif)
![EASL9.gif](../images/051815/051815-1/EASL9.gif)
![EASL10.gif](../images/051815/051815-1/EASL10.gif)
![EASL11.gif](../images/051815/051815-1/EASL11.gif)
![EASL12.gif](../images/051815/051815-1/EASL12.gif)
![EASL13.gif](../images/051815/051815-1/EASL13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|